Jacob Chacko

Jacob M.
Chacko is President, Chief Executive Officer & Director at Oric Pharmaceuticals, Inc. since 2019.
He is Chairman at Bright Peak Therapeutics AG and Bright Peak Therapeutics, Inc. since 2021.
He serves as Director at Arog Pharmaceuticals, Inc. and as Independent Director at 4D Molecular Therapeutics, Inc. since 2019.
Formerly, Dr. Chacko was Director at RentPath LLC from 2011 to 2014, Independent Non-Executive Director at Turning Point Therapeutics, Inc. from 2018 to 2021, Director at Lucile Salter Packard Children's Hospital at Stanford from 2013 to 2017, Director at Envision Pharmaceutical Services LLC from 2013 to 2014, Director at Bonti, Inc. in 2018, Director at Packard Children's Health Alliance in 2018, Director at Envision Rx Options Holdings, Inc. from 2013 to 2014, Chief Financial Officer at Ignyta, Inc. from 2014 to 2018, and Vice President at TPG Capital LP from 2008 to 2014.
Education includes graduate studies at the University of Oxford, undergraduate studies at the University of Southern California, a doctorate from the University of California, Los Angeles, and an MBA from Harvard Business School.